GlassScriptPhysician profile
Jennifer M Lee
NPI 1922201581
$318,392.45
in general payments reported to CMS, 2019-2025
21 companies · $26K in 2025
The $26K reported for 2025 was more than what 98% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $30K · 2021: $65K · 2022: $75K · 2023: $55K · 2024: $56K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $114K · Travel and Lodging: $12K · Food and Beverage: $6,425 · Consulting Fee: $3,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $113,750.00 |
| Travel and Lodging | $12,368.92 |
| Food and Beverage | $6,424.87 |
| Consulting Fee | $3,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $306,905.72 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Therapies |
| Surgalign Spine Technologies, INC. | $4,032.07 | 2020 | |
| Abbott Laboratories | $1,966.53 | 2019-2025 | Proclaim, Eterna, Freestyle Libre 3 |
| Mml US, INC. | $1,792.25 | 2022-2023 | Reactiv8 |
| Medtronic, INC. | $1,413.63 | 2022-2023 | Intellis Adaptivestim |
| Relievant Medsystems, INC. | $632.85 | 2021 | |
| Spr Therapeutics, INC | $320.45 | 2023-2025 | Sprint Pns System |
| Abiomed | $216.08 | 2024 | Impella |
| Nevro Corp. | $182.15 | 2019-2023 | Senza |
| Biotronik Nro, INC. | $173.16 | 2023 | Biotronik |
| Nalu Medical, INC. | $135.89 | 2023-2025 | Nalu Neurostimulation System |
| Stimwave Technologies Incorporated | $116.99 | 2022 | |
| Abbvie INC. | $112.01 | 2023-2024 | |
| Averitas Pharma INC. | $102.67 | 2023-2024 | Qutenza |
| Si-Bone, INC. | $92.38 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $44.70 | 2023 | Belbuca |
| Saluda Medical Americas, INC. | $41.50 | 2024 | Evoke |
| Vertos Medical, INC. | $36.62 | 2024 | Mild Device Kit |
| Fidia Pharma USA INC. | $25.76 | 2024 | Hymovis, Hyalgan, Triluron |
| Pfizer INC. | $24.72 | 2023 | |
| Phadia US INC. | $24.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.